Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option

Journal Article Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option Get access Xuekun Wu, Xuekun Wu Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USADepartment of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA, USA https://orcid.org/0000-0001-5429-3126 Search for other works by this author on: Oxford Academic PubMed Google Scholar Francesca Vacante, Francesca Vacante Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USADepartment of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA, USA https://orcid.org/0000-0001-5702-7253 Search for other works by this author on: Oxford Academic PubMed Google Scholar Joseph C Wu Joseph C Wu Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USADepartment of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA, USADepartment of Radiology, Stanford University School of Medicine, Stanford, CA, USA Corresponding author. Tel: +1 650 736 2246, Fax: +1 650 736 0234, Email: joewu@stanford.edu https://orcid.org/0000-0002-6068-8041 Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, Volume 44, Issue 19, 14 May 2023, Pages 1761–1763, https://doi.org/10.1093/eurheartj/ehad058 Published: 17 March 2023